MARKETS
Company

CORRECTION: Attovia Therapeutics IPO Shares Open For Trade At $21/Share; IPO Priced At $17/Share On 17M Shares

Aug 5, 2026 · 12:22 PM ET· updated 1h ago

Share
Why It Matters

Attovia just started selling its stock to the public, and people wanted to buy it at a higher price than planned—$21 instead of $17. This shows people are excited about the company, but we can't know if that excitement will last.

This read is generated by AI from raw market data and is for education only. It is not financial advice, not a signal, and not a recommendation to buy or sell.
Tickers in Play

Last session drawn · prints held ~15 minutes · licensed exchange data

Source: Benzinga · Read the original report at the publisher. Headline and figures shown for context; data may be delayed.

Disclosure: Educational and informational purposes only — not financial advice. We educate, not advise. Market data may be delayed up to 15 minutes unless marked real-time. Past performance is not indicative of future results.